Topic

Natpara (parathyroid hormone)

A collection of 29 issues

Denied for Natpara by UnitedHealthcare in New Jersey? Complete 2025 Appeal Guide & Alternative Coverage Options

Answer Box: Natpara was discontinued by Takeda in December 2024, making new prescriptions impossible. If denied coverage for alternative parathyroid hormone treatments like Yorvipath, New Jersey patients can appeal through UnitedHealthcare's internal process (180 days), then New Jersey's Independent Health Care Appeals Program (IHCAP) via Maximus

Getting Natpara (Parathyroid Hormone) Coverage from Aetna CVS Health in New York: 2025 Discontinuation Guide and Alternative Options

Answer Box: Natpara Coverage Status in New York Natpara (parathyroid hormone) is no longer available for new prescriptions as Takeda discontinued global manufacturing in December 2024. Aetna CVS Health automatically denies all new Natpara requests regardless of medical necessity. For New York patients: 1) Discuss Yorvipath (FDA-approved August 2024) with

Renewing Natpara (Parathyroid Hormone) Approval with Cigna in New York: 2025 Discontinuation Guide

Answer Box: Renewing Natpara with Cigna in New York Current Natpara patients can renew coverage with Cigna through December 2025, but must act quickly due to Takeda's global discontinuation. Submit renewal requests 90 days before expiration with updated labs (serum calcium, PTH, 25-OH vitamin D), endocrinologist documentation of

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Texas: Appeals Guide for Discontinued Drug

Answer Box: Getting Natpara (Parathyroid Hormone) Covered by Cigna in Texas Important: Natpara was discontinued by Takeda in December 2024, with the U.S. Special Use Program ending December 31, 2025. New prescriptions are no longer available. However, if you received a Cigna denial for Natpara before discontinuation or need

How to Get Natpara (Parathyroid Hormone) Covered by Humana in New York: Appeals Guide for Discontinued Drug

Answer Box: Natpara Coverage Status Natpara (parathyroid hormone) is permanently discontinued as of December 31, 2025. Humana automatically denies new Natpara prescriptions because there's no commercial supply. Instead, focus on getting alternative treatments covered like optimized calcium/calcitriol or Yorvipath. For Humana Medicare denials in New York, you

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in North Carolina: Complete 2025 Appeals Guide

Answer Box Getting Natpara (parathyroid hormone) covered by Cigna in North Carolina requires understanding that Takeda discontinued manufacturing in December 2024. New starts are typically denied due to lack of commercial supply. For existing patients, you'll need prior authorization showing chronic hypoparathyroidism, failed conventional therapy (calcium + active vitamin

Getting Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Pennsylvania: 2026 Discontinuation Guide and Alternative Coverage

Answer Box: Natpara Coverage Status with Aetna CVS Health in Pennsylvania Natpara (parathyroid hormone) is no longer available as Takeda discontinued manufacturing in December 2024, with the U.S. Special Use Program ending December 31, 2025. Aetna CVS Health now automatically denies new Natpara prescriptions due to lack of commercial

How to Get Natpara (Parathyroid Hormone) Covered by UnitedHealthcare in Virginia: 2025 Discontinuation Guide and Appeals Process

Answer Box: Quick Path to Coverage Natpara (parathyroid hormone) is no longer commercially available after Takeda's December 2024 discontinuation. UnitedHealthcare now denies new prescription requests, but existing patients in the Special Use Program may qualify for coverage through December 2025 with proper prior authorization. First step: Contact your

Myths vs. Facts: Getting Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Michigan

Important Update: Takeda will permanently discontinue all Natpara shipments on December 31, 2025. New patient starts are typically denied due to no commercial supply. If you're currently on Natpara through the Special Use Program, work with your endocrinologist immediately to plan your transition to alternatives like Yorvipath or

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Pennsylvania: Complete Requirements Guide

Answer Box: Getting Natpara Covered by Cigna in Pennsylvania Who's eligible: Adults with chronic hypoparathyroidism who've failed maximized calcium and vitamin D therapy, with documented low PTH levels on two separate tests. Fastest path to approval: 1. Submit prior authorization through CignaforHCP.com with complete lab